Sec. 4. Guidance on value-based purchasing arrangements for inpatient drugs under Medicaid
195 words·~1 min read·
/bill/118/hr/2666/rh/section-4A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue guidance to State Medicaid agencies on the option of entering into a value-based purchasing arrangement (as defined in section 1927(k)(12) of the Social Security Act ( 42 U.S.C. 1396r–8(k)(12) )) with manufacturers for drugs or biological products provided as part of, or as incident to and in the same setting as, inpatient hospital services furnished under a State plan under title XIX of the Social Security Act ( 42 U.S.C. 1396 et seq. ), or under a waiver of such plan, where such drugs or biological products are reimbursed directly and not paid for as part of payment for such inpatient hospital services, including guidance on how multiple States may enter into agreements with one another and with manufacturers which permit the transfer of funds between the participating States so that individuals who reside in a State different from the State in which they receive a drug subject to a value-based purchasing arrangement as an inpatient may be treated as if they received such drug in the State in which they reside.
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- 42 USC 1396r–8(k)(12)
Citation graph
cites case law
Sec. 4
Guidance on value-based purchasing arrangements for inpatient drugs under Medicaid
Cite42 USC 1396r–8(k)(12)
Cites 2Cited by 0 across 0 sources